BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1083922)

  • 1. Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: studies in hepatic and non-hepatic diseases.
    Meyer zum Büschenfelde KH; Alberti A; Arnold W; Freudenberg J
    Klin Wochenschr; 1975 Nov; 53(22):1061-7. PubMed ID: 1083922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immune reactivity to hepatitis B surface antigen in liver diseases.
    de Moura MC; Vernace SJ; Paronetto F
    Gastroenterology; 1975 Aug; 69(2):310-17. PubMed ID: 1080122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
    Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
    Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis.
    Lee WM; Reed WD; Mitchell CG; Galbraith RM; Eddleston AL; Zuckerman AJ; Williams R
    Br Med J; 1975 Mar; 1(5960):705-8. PubMed ID: 1125673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cell-mediated immunity to hepatitis B virus antigens in acute and chronic liver disease.
    Aldershvile J; Dietrichson O; Hardt F; Nielsen JO; Skinhöj P
    Scand J Gastroenterol; 1977; 12(8):917-22. PubMed ID: 605351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the pathogenesis of chronic inflammatory liver diseases. I. Membrane-fixed IgG on isolated hepatocytes from patients.
    Hopf U; Arnold W; Meyer zum Büschenfelde KH; Förster E; Bolte JP
    Clin Exp Immunol; 1975 Oct; 22(1):1-8. PubMed ID: 765015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
    Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunology of liver diseases].
    Meyer zum Büschenfelde KH
    Schweiz Med Wochenschr; 1987 Jul; 117(29):1065-75. PubMed ID: 3313682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid-phase radioimmunoassay.
    Manns M; Meyer zum Büschenfelde KH; Hütteroth TH; Hess G
    Clin Exp Immunol; 1980 Nov; 42(2):263-72. PubMed ID: 6781800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies and Australia antigen in acute and chronic liver].
    Fargion SR; Del Ninno E; Cappellini MD; Fiorelli G
    Minerva Med; 1974 Feb; 65(13):723-8. PubMed ID: 4545217
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B antigen and auto-antibodies in chronic liver diseases in Hong Kong.
    Lee AK
    Aust N Z J Med; 1975 Jun; 5(3):235-9. PubMed ID: 169780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.
    Hopf U; Meyer zum Büschenfelde KH; Arnold W
    N Engl J Med; 1976 Mar; 294(11):578-82. PubMed ID: 1107836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Liver-specific proteins and autoimmunity in inflammatory liver diseases].
    Alberti A; Realdi G; Bortolotti F; Trevisan A; Tremolada F; Rigoli A
    Boll Ist Sieroter Milan; 1976; 55(5):411-25. PubMed ID: 1016592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathology of liver disease.
    Doniach D; Walker G
    Prog Liver Dis; 1972; 4():381-402. PubMed ID: 4569005
    [No Abstract]   [Full Text] [Related]  

  • 17. The diagnostic significance of intrahepatocellular hepatitis-B-surface-antigen (HBsAg), hepatitis-B-core-antigen (HBcAg) and IgG for the classification of inflammatory liver diseases. (Studies on HBsAg-positive and -negative patients).
    Arnold W; Meyer zum Büschenfelde KH; Hess G; Knolle J
    Klin Wochenschr; 1975 Nov; 53(22):1069-74. PubMed ID: 1226039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infection due to hepatitis B virus and host immune response].
    Realdi G; Bortolotti F; Alberti A; Fattovich G; Ongaro G
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):323-34. PubMed ID: 1016586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
    Meyer zum Büschenfelde KH; Manns M; Hütteroth TH; Hopf U; Arnold W
    Clin Exp Immunol; 1979 Aug; 37(2):205-12. PubMed ID: 498582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-cell-membrane autoantibody specific for inflammatory liver diseases.
    Tage-Jensen U; Arnold W; Dietrichson O; Hardt F; Hopf U; Meyer Zum Büschenfelde KH; Nielsen JO
    Br Med J; 1977 Jan; 1(6055):206-8. PubMed ID: 832076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.